Stock 6794 UNICOCELL BIOMED CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company UnicoCell Biomed Co., Ltd.

Equities

6794

TW0006794001

Biotechnology & Medical Research

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-04-22 pm EDT 		5-day change 1st Jan Change
84 TWD -1.06% Intraday chart for UnicoCell Biomed Co., Ltd. +7.14% +1.20%
Mar. 07 UnicoCell Biomed Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Unicocell Biomed Co Ltd is mainly engaged in the research and development of new adipose stem cell drugs and the application of stem cell technology. The main products include stem cell secretin and cell testing services. The Company's current development projects are divided into human adipose-derived mesenchymal stem cells, autologous adipose stem cell transplantation and cell preparation application products. The clinical trials of human adipose-derived mesenchymal stem cells include the ELIXCYTE-CT21 clinical trial project and the ELIXCYTE-CT31 clinical trial project. Autologous adipose stem cell transplantation is used for large-area burns and difficult wound healing. The cell preparation application products include stem cell secretin, which is a conditioned medium derived from cultured stem cells, used to improve skin dullness and fine lines.

Sales per Business

TWD in Million2022Weight2023Weight Delta
Stem Cell Secretion
50.2 %
12 83.6 % 12 50.2 % +2.50%
Cell Preparation
49.8 %
2 16.4 % 12 49.8 % +418.05%

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
100.0 %
14 100.0 % 25 100.0 % +70.79%

Managers

Managers TitleAgeSince
Chia Chu Tsai CEO
 Chief Executive Officer - 18-03-27
Pei Lin Chen DFI
 Director of Finance/CFO - 18-08-27
I Wen Tsai CHM
 Chairman - 18-07-31
Chia Che Tsai CTO
 Chief Tech/Sci/R&D Officer - 18-07-31

Members of the board

Members of the board TitleAgeSince
Chia Fang Chang BRD
 Director/Board Member - 20-10-11
Ming Te Wang BRD
 Director/Board Member - 20-10-11
Su Lan Lin BRD
 Director/Board Member - 20-10-11
I Wen Tsai CHM
 Chairman - 18-07-31
Chia Chu Tsai CEO
 Chief Executive Officer - 18-03-27
Hsiu Mei Hsieh BRD
 Director/Board Member - 18-03-27
Cheng Jen Chen BRD
 Director/Board Member - 20-10-11
Mei Hua Ling BRD
 Director/Board Member - 20-10-11
I Chen Hsieh BRD
 Director/Board Member - 19-04-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 55,685,000 18,060,627 ( 32.43 %) 0 32.43 %

Company contact information

UnicoCell Biomed Co., Ltd.

6th Floor No. 65, Lane 77, Xingai Road

114 94, Taipei

+

http://www.unicocell.com
address UnicoCell Biomed Co., Ltd.(6794)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sales per Business

Sector Bio Therapeutic Drugs

1st Jan change Capi.
UNICOCELL BIOMED CO., LTD. Stock UnicoCell Biomed Co., Ltd.
+1.20% 145M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-0.49% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+3.31% 96.73B
ARGENX SE Stock argenx SE
+1.66% 21.31B
BIONTECH SE Stock BioNTech SE
-16.16% 21.21B
GENMAB A/S Stock Genmab A/S
-6.82% 18.79B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.41% 16.37B
BEIGENE, LTD. Stock BeiGene, Ltd.
-22.87% 13.68B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+6.32% 13.44B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+21.46% 10.98B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 6794 Stock
  4. Company UnicoCell Biomed Co., Ltd.